Allspring Global Investments
ADMA icon

Allspring Global Investments’s ADMA Biologics ADMA Stock Holding History

Allspring Global Investments’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$265K Sell
30,771
-448,808
-94% -$4.09M ﹤0.01% 1603
2026
Q1 		$4.37M Sell
479,579
-10,565
-2% -$167K 0.01% 892
2025
Q4 		$8.76M Sell
490,144
-1,057,995
-68% -$17.8M 0.01% 740
2025
Q3 		$23.3M Sell
1,548,139
-1,772,112
-53% -$30.4M 0.04% 502
2025
Q2 		$59.4M Buy
3,320,251
+271,305
+9% +$5.53M 0.1% 244
2025
Q1 		$59.2M Buy
3,048,946
+207,097
+7% +$3.58M 0.1% 250
2024
Q4 		$51M Buy
2,841,849
+2,613,482
+1,144% +$49.2M 0.08% 293
2024
Q3 		$4.57M Buy
228,367
+17,573
+8% +$273K 0.01% 967
2024
Q2 		$2.36M Sell
210,794
-41,808
-17% -$351K ﹤0.01% 1131
2024
Q1 		$1.67M Buy
252,602
+7,463
+3% +$40.8K ﹤0.01% 1241
2023
Q4 		$1.11M Sell
245,139
-34,332
-12% -$127K ﹤0.01% 1317
2023
Q3 		$1M Buy
279,471
+81,995
+42% +$316K ﹤0.01% 1359
2023
Q2 		$729K Buy
197,476
+79,320
+67% +$294K ﹤0.01% 1486
2023
Q1 		$391K Buy
118,156
+83,660
+243% +$289K ﹤0.01% 1642
2022
Q4 		$134K Sell
34,496
-669
-2% -$2.06K ﹤0.01% 1958
2022
Q3 		$85K Buy
+35,165
New +$84.4K ﹤0.01% 2142

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Allspring Global Investments's ADMA Position: Q2 2026 in Review

Allspring Global Investments reduced its ADMA Biologics (ADMA) stake by 94% in Q2 2026, selling an estimated $4.09M and leaving 30,771 shares worth $265K. The position accounts for ﹤0.01% of the portfolio, ranked #1603.

Allspring Global Investments first reported a position in ADMA in Q3 2022 and has held it in 16 quarters since. The position peaked at $59.4M in Q2 2025. 323 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • Allspring Global Investments held 30,771 shares of ADMA Biologics worth $265K as of Q2 2026.
  • Allspring Global Investments sold 448,808 ADMA Biologics shares in Q2 2026, an estimated $4.09M.
  • ADMA Biologics made up ﹤0.01% of Allspring Global Investments's portfolio in Q2 2026, its #1603 holding.
  • Allspring Global Investments first reported a position in ADMA Biologics in Q3 2022 and has held it in 16 quarters since.
  • Allspring Global Investments's ADMA Biologics position peaked at $59.4M in Q2 2025.
  • 323 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.